Westborough, MA, United States of America

Wen Lin Seng

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2003-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Wen Lin Seng

Introduction

Wen Lin Seng is an accomplished inventor based in Westborough, MA (US). He has made significant contributions to the field of ocular research, particularly through his innovative methods involving teleosts, such as zebrafish. With a total of 4 patents to his name, his work has the potential to advance our understanding of ocular diseases and disorders.

Latest Patents

Wen Lin Seng's latest patents focus on methods of screening agents for activity in isolated eyes of teleosts. These patents provide comprehensive methodologies for isolating eyes from zebrafish and screening agents for ocular activity. His inventions include high-throughput methods for screening agents in multi-well plates, which can be crucial for testing potential treatments for ocular diseases. The detailed approaches outlined in his patents aim to assess cell death and toxic activity in the eye and other tissues, thereby enhancing the research capabilities in ocular pharmacology.

Career Highlights

Wen Lin Seng is currently associated with Phylonix Pharmaceuticals, Inc., where he continues to innovate in the field of ocular research. His work is characterized by a commitment to developing effective screening methods that can lead to breakthroughs in understanding and treating eye-related conditions.

Collaborations

Wen Lin Seng collaborates with notable colleagues, including Patricia McGrath and George N Serbedzija. These partnerships enhance the research environment and foster innovative solutions in the field of ocular health.

Conclusion

Wen Lin Seng's contributions to ocular research through his patents and collaborations position him as a key figure in the advancement of methods for screening ocular agents. His work not only reflects his expertise but also holds promise for future innovations in the treatment of eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…